Ruth Wertheimer

Portfolio · 1

Chiasma

Oral Therapeutic Options for Patients with Rare Diseases

1 round $33.5M committed Latest: 2014-12

Investment activity

1 portfolio exit on record.

Q&A

What is Ruth Wertheimer's primary investment focus by sector?

Ruth Wertheimer primarily focuses on the Health Tech & Life Sciences sector, with all recorded portfolio companies and exits falling within this area.

Can you name a notable exit for Ruth Wertheimer?

A notable exit for Ruth Wertheimer is Chiasma, which went public on NASDAQ in July 2015 with a valuation of $562M.

What is Ruth Wertheimer's most recent investment activity?

Ruth Wertheimer's most recent recorded investment activity was in December 2014, with one new portfolio company added that year.

What type of funding rounds has Ruth Wertheimer participated in?

Ruth Wertheimer has participated in D Round funding stages.

What is the total capital raised by Chiasma, a portfolio company of Ruth Wertheimer?

Chiasma, a portfolio company of Ruth Wertheimer, raised $293.7M in total funding before its acquisition.

When was Ruth Wertheimer's most recent exit event?

Ruth Wertheimer's most recent exit event was in July 2015, when Chiasma went public.